InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today ...
After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback